Outside of the current metabolic crisis, a serum bicarbonate (CO₂) level that fluctuates between 19 and 25 mEq/L—does this support a diagnosis of succinyl‑CoA:3‑oxoacid CoA‑transferase (SCOT) deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Baseline Serum CO₂ of 19-25 mEq/L Does NOT Strongly Support SCOT Deficiency

A serum bicarbonate fluctuating between 19-25 mEq/L outside of acute crises is NOT characteristic of SCOT deficiency and argues against this diagnosis. The hallmark biochemical feature of SCOT deficiency is permanent ketonuria or persistent ketosis between crises, not chronic mild metabolic acidosis 1, 2.

Key Biochemical Features of SCOT Deficiency

What You Should Actually See:

  • Permanent ketonuria is the pathognomonic finding between acute episodes 1, 2
  • Urinary ketone bodies typically range from 1+ to 3+ on ketostix even when asymptomatic 3
  • Marked elevation of acetoacetate and 3-beta-hydroxybutyrate on urine organic acid analysis by GC-MS 4
  • Normal serum bicarbonate between ketoacidotic crises is the expected pattern 1

During Acute Crises (Not Your Patient's Baseline):

  • Severe ketoacidosis with pH <7.1 2, 5
  • Bicarbonate levels dropping to 5-6 mEq/L 3, 2
  • Total ketone bodies reaching 29 mmol/L or higher 3

Why Your Patient's Pattern Doesn't Fit

Your patient shows chronic mild-to-borderline low bicarbonate (19-25 mEq/L) without mention of persistent ketonuria. This pattern suggests:

  1. Chronic metabolic acidosis from another cause (renal tubular acidosis, chronic diarrhea, other organic acidurias)
  2. Compensated respiratory alkalosis (if this represents total CO₂)
  3. Normal variation at the lower end (22-28 mEq/L is typical normal range)

Important Caveats About "Permanent Ketosis"

While permanent ketonuria is considered pathognomonic 2, recent evidence shows this is not absolute:

  • One case with significant residual SCOT activity (T435N mutation) showed only intermittent ketonuria, not permanent 3
  • Environmental factors and residual enzyme activity influence the degree of baseline ketosis 2
  • However, even these atypical cases still showed intermittent ketonuria, not chronic low bicarbonate 3

What to Do Next

Check urinary ketones repeatedly during asymptomatic periods - this is far more diagnostic than serum bicarbonate levels:

  • If persistently positive (1+ to 3+) → supports SCOT deficiency
  • If consistently negative → argues strongly against SCOT deficiency

Obtain urine organic acid analysis by GC-MS 6 looking specifically for:

  • Elevated acetoacetate and 3-beta-hydroxybutyrate between crises
  • This is the definitive screening test per ACMG guidelines 6

Consider alternative diagnoses for chronic low-normal bicarbonate:

  • Proximal or distal renal tubular acidosis
  • Other organic acidurias (methylmalonic, propionic, glutaric acidemia type I) 6
  • Mitochondrial disorders affecting energy metabolism 6

Bottom Line

The serum CO₂ pattern you describe (19-25 mEq/L baseline) is inconsistent with typical SCOT deficiency and should prompt investigation for other causes of chronic metabolic acidosis. SCOT deficiency patients maintain normal acid-base status between crises but demonstrate persistent ketone body elevation 1, 2.

References

4
Research

[Succinyl CoA:3 oxoacid CoA transferase deficiency: A case report].

Revista medica del Instituto Mexicano del Seguro Social, 2023

Related Questions

Is there a link between succinyl‑CoA:3‑oxoacid CoA‑transferase (SCOT) deficiency or transcobalamin‑II (T2) deficiency and anemia of chronic disease or iron‑deficiency anemia?
In a patient who had a ketotic hypoglycemia episode with marked metabolic acidosis (low serum bicarbonate), is mitochondrial acetoacetyl‑CoA thiolase (T2) deficiency or succinyl‑CoA:3‑oxoacid CoA‑transferase (SCOT) deficiency more likely?
What are the contraindications for using midodrine, including uncontrolled supine hypertension, severe cardiovascular disease, pheochromocytoma, urinary retention, severe peripheral arterial disease, acute renal failure, severe hepatic impairment, hypersensitivity, and pregnancy?
What is the appropriate dose of octreotide for sulfonylurea‑induced hypoglycemia?
Do glucocorticoids enhance tissue healing or merely reduce inflammation?
What is the recommended emergency management for a patient who ingested a toxic dose (>300 mg/kg) of a medication within the past hour, with risk of seizures and cardiovascular instability?
How can insulin resistance be reliably reversed in a reproductive‑age woman with polycystic ovary syndrome?
What are the current effective radiation doses for common imaging modalities (e.g., chest X‑ray, mammogram, CT, PET/CT, nuclear scans) with recent dose‑reduction technologies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question